Enzymatic analysis of α-ketoglutaramate—A biomarker for hyperammonemia
Abstract
No abstract availableKeywords
Funding Information
- NSF (CBET-1066397)
- National Institutes of Cancer (ES008421)
This publication has 26 references indexed in Scilit:
- Glutamine in the pathogenesis of acute hepatic encephalopathyNeurochemistry International, 2012
- Encephalopathy in acute liver failure resulting from acetaminophen intoxication: New observations with potential therapy*Critical Care Medicine, 2011
- Urinary 2-hydroxy-5-oxoproline, the lactam form of α-ketoglutaramate, is markedly increased in urea cycle disordersAnalytical and Bioanalytical Chemistry, 2011
- Astrocyte Glutamine Synthetase: Importance in Hyperammonemic Syndromes and Potential Target for TherapyNeurotherapeutics, 2010
- Hepatic glutamate metabolism: a tale of 2 hepatocytesThe American Journal of Clinical Nutrition, 2009
- Assay and purification of ω-amidase/Nit2, a ubiquitously expressed putative tumor suppressor, that catalyzes the deamidation of the α-keto acid analogues of glutamine and asparagineAnalytical Biochemistry, 2009
- Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic EncephalopathyJournal of Cerebral Blood Flow & Metabolism, 1991
- Microdetermination of 2-ketoglutaric acid in plasma and cerebrospinal fluid by capillary gas chromatography mass spectrometry; application to pediatricsJournal of Mass Spectrometry, 1984
- THE GLUTAMINE TRANSAMINASE‐ω‐AMIDASE SYSTEM IN RAT AND HUMAN BRAIN1Journal of Neurochemistry, 1977
- Rat liver ι-amidase. Purification and propertiesBiochemistry, 1971